BeyondSpring Inc. (BYSI)
NASDAQ: BYSI · Real-Time Price · USD
1.500
+0.120 (8.70%)
Apr 23, 2025, 4:00 PM EDT - Market closed
BeyondSpring Market Cap
BeyondSpring has a market cap or net worth of $60.47 million as of April 23, 2025. Its market cap has decreased by -43.00% in one year.
Market Cap
60.47M
Enterprise Value
58.14M
1-Year Change
-43.00%
Ranking
Category
Stock Price
$1.50
Market Cap Chart
Since March 9, 2017, BeyondSpring's market cap has decreased from $362.10M to $60.47M, a decrease of -83.30%. That is a compound annual growth rate of -19.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 22, 2025 | 54.80M | -16.59% |
| Dec 31, 2024 | 65.70M | 87.18% |
| Dec 29, 2023 | 35.10M | -52.05% |
| Dec 30, 2022 | 73.20M | -58.71% |
| Dec 31, 2021 | 177.30M | -52.38% |
| Dec 31, 2020 | 372.30M | -7.48% |
| Dec 31, 2019 | 402.40M | -4.76% |
| Dec 31, 2018 | 422.50M | -32.59% |
| Dec 29, 2017 | 626.80M | 73.10% |
View and export this data all the way back to 2017.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 741.51B |
| UnitedHealth Group | 394.41B |
| Johnson & Johnson | 377.51B |
| AbbVie | 301.33B |
| Novo Nordisk | 284.50B |
| Abbott Laboratories | 224.25B |
| Novartis AG | 209.93B |
| AstraZeneca | 208.11B |